Calcium Acetate: Package Insert and Label Information (Page 2 of 2)

16 HOW SUPPLIED/STORAGE AND HANDLING

Calcium Acetate capsules USP, 667 mg are hard gelatin capsules with blue opaque cap imprinted with “SUVEN” in white color ink and a white opaque body imprinted with “667” blue color ink. Each capsule contains 667 mg calcium acetate (anhydrous Ca(CH 3 COO) 2 ; MW=158.17 grams) equal to 169 mg (8.45 mEq) calcium.
NDC 16571-813-20 Bottles of 200 with child-resistant closure.

STORAGE

Store at 20°-25°C (68°-77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].

17 PATIENT COUNSELING INFORMATION

Inform patients to take calcium acetate capsules with meals, adhere to their prescribed diets, and avoid the use of calcium supplements including nonprescription antacids. Inform the patients about the symptoms of hypercalcemia [ see Warnings and Precautions (5.1) and Adverse Reactions (6.1) ].


Advise patients who are taking an oral medication where reduction in the bioavailability of that medication would have clinically significant effect on its safety or efficacy to take the drug one hour before or three hours after calcium acetate capsules.

Manufactured by:

Suven Pharmaceuticals Limited
Pashamylaram, Telangana, 502307, India
ML No: 24/MD/AP/2009/F/CC

Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816

Revised: 09/2022

Lb50318-3-01

Calcium Acetate Capsules USP

Rising Pharmaceuticals NDC 16571-813-20

Calcium Acetate

Capsules USP

667 mg*

200 Capsules Rx Only

*Each capsule contains: 667 mg calcium

acetate, USP equivalent to 169 mg calcium

DIRECTIONS: SWALLOW CAPSULE. DO NOT

CHEW. Take as directed by your physician.

KEEP THIS AND ALL DRUGS OUT OF REACH

OF CHILDREN.

Store at 20° to 25°C (68° to 77°F); excursions

permitted to 15° to 30°C (59° to 86°F) [See USP

Controlled Room Temperature].

Manufactured By:

Suven Pharmaceuticals Limited
Pashamylaram, Telangana, 502307, India

M.L No.: 24/MD/AP/2009/F/CC

Distributed By:

Rising Pharma Holdings, Inc.
East Brunswick, NJ, 08816

Lb50318-1-00 Rev. 08/2021

Label
(click image for full-size original)
CALCIUM ACETATE calcium acetate capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16571-813
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CALCIUM ACETATE (CALCIUM CATION) CALCIUM ACETATE 667 mg
Inactive Ingredients
Ingredient Name Strength
D&C RED NO. 28 0.0061 mg
WATER 13.9592 mg
FD&C BLUE NO. 1 0.0555 mg
FD&C BLUE NO. 1 ALUMINUM LAKE 0.0728 mg
Product Characteristics
Color blue (Cap, Opaque) , white (Body,Opaque) Score score with uneven pieces
Shape CAPSULE Size 22mm
Flavor Imprint Code Suven;667
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16571-813-20 200 CAPSULE in 1 BOTTLE, PLASTIC None
Image of Product
(click image for full-size original)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA211038 11/01/2021
Labeler — Rising Pharma Holdings, Inc. (835513529)
Establishment
Name Address ID/FEI Operations
Suven Pharmaceuticals Limited 677604288 manufacture (16571-813), api manufacture (16571-813), analysis (16571-813), pack (16571-813), label (16571-813)

Revised: 10/2022 Rising Pharma Holdings, Inc.

Page 2 of 2 1 2

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.